Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
186.00    0.90 (0.49%)
Bid:
186.00
Ask:
186.10
Spread: 0.10 (0.054%)
Market Cap: £8.42b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Directorate Change

22 Nov 2023 16:15

RNS Number : 3686U
Centrica PLC
22 November 2023
 

 

 

22 November 2023

Centrica plc

('Centrica' or 'the Company')

 

Centrica appoints Non-Executive Directors

 

Centrica plc is pleased to announce the appointment of Jo Harlow and Sue Whalley as Non-Executive Directors of the Company with effect from 1 December 2023, whereupon Jo and Sue will also become members of the Company's Remuneration Committee and Nominations Committee.

 

Scott Wheway, Chair of Centrica, said: "I look forward to welcoming Jo and Sue to the Board as Non-Executive Directors. Jo will bring extensive knowledge on the use of technology and data to enhance product development and drive growth in consumer businesses. Sue brings a blend of experience in people and cultural transformation, and strategic, technological, and operational evolution in large, complex organisations. Their valuable experience will be of great benefit to Centrica."

 

Notes

 

1.

This announcement is made pursuant to LR 9.6.11R of the Listing Rules. 

 

2.

In accordance with the obligations under LR 9.6.13R(1) of the Listing Rules, Jo Harlow currently holds the following non-executive directorships in quoted companies:

· J Sainsbury plc

· Halma plc

· InterContinental Hotels Group PLC

Jo was previously a non-executive director of Ceconomy AG (Deutsche Börse) from 2017 to 2021.

 

3.

There is no further information to be disclosed in respect of Jo Harlow or Sue Whalley pursuant to LR 9.6.13R (1) to (6) inclusive of the Listing Rules.

 

4.

At the date of this announcement, Jo Harlow has no beneficial interest in ordinary shares of Centrica plc. At the date of this announcement, Sue Whalley and persons closely associated with Sue have a beneficial interest in 13,868 ordinary shares of Centrica plc.

 

 

 

ENDS

 

Enquiries:

Investors and AnalystsT: 01753 494900E: ir@centrica.com

MediaT: 01784 843000E: media@centrica.com

 

Notes to Editors:

 

Jo Harlow has more than 25 years' experience working in various senior roles, predominantly in the branded and technology sectors. Prior to her non-executive career, Jo held the position of Corporate Vice President of the Phones Business Unit at Microsoft. She previously spent 11 years at Nokia Corporation in a number of senior management roles, including Executive Vice President of Smart Devices. Jo currently serves as Non-Executive Director and Remuneration Committee Chair at InterContinental Hotels Group PLC and J Sainsbury plc, and as Senior Independent Director and Remuneration Committee Chair at Halma plc. She is also a Non-Executive Director at Chapter Zero Limited. Jo will be retiring from the Board of InterContinental Hotels Group PLC on 31 December 2023. Jo was also previously a Non-Executive Director of Ceconomy AG from 2017 to 2021. She attended Duke University in North Carolina and has a BSc in Psychology.

 

Sue Whalley is Chief People and Performance Officer at Associated British Foods plc (ABF), having been appointed to the role in 2019. Prior to joining ABF, Sue spent 12 years at Royal Mail Group, where she held a number of executive roles including Chief Executive Officer of the Post & Parcels division and Chief Operations Officer. Prior to that, Sue was a Partner at McKinsey & Company where she spent nearly 18 years in management consultancy. Sue is a graduate of University of Cambridge and holds an MBA from Harvard Business School.

 

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABTBATMTATBIJ
Date   Source Headline
1st Jun 20263:45 pmRNSTotal Voting Rights
26th May 202612:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
18th May 20264:00 pmRNSDirector/PDMR Shareholding
15th May 20267:00 amRNSBritish Gas agrees PPM settlement
14th May 20264:42 pmRNSPublication of a Prospectus
12th May 20263:15 pmRNSDirector/PDMR Shareholding
12th May 202612:15 pmRNSDirector/PDMR Shareholding
12th May 20267:10 amRNSDirectorate change
7th May 202612:15 pmRNSResult of AGM
7th May 20267:00 amRNSAcquisition of the Severn CCGT for c.£370 million
7th May 20267:00 amRNSAGM Statement
1st May 20262:30 pmRNSTotal Voting Rights
27th Apr 20262:30 pmRNSDirector/PDMR Shareholding
13th Apr 20263:30 pmRNSDirector/PDMR Shareholding
1st Apr 202612:00 pmRNSTotal Voting Rights
31st Mar 202610:33 amRNSNotice of AGM
25th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20266:15 pmRNSDirector/PDMR Shareholding
2nd Mar 202612:15 pmRNSTotal Voting Rights
25th Feb 20265:15 pmRNSDirector/PDMR Shareholding
19th Feb 20262:39 pmRNSAnnual Financial Report 2025
19th Feb 20267:10 amRNSDirectorate change
19th Feb 20267:00 amRNSPreliminary Results
11th Feb 20265:30 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSCentrica announces divestments
2nd Feb 20263:00 pmRNSTotal Voting Rights
26th Jan 20264:15 pmRNSDirector/PDMR Shareholding
13th Jan 20263:00 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:09 pmRNSTransaction in Own Shares - Replacement
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202612:30 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.